172 related articles for article (PubMed ID: 18630065)
1. [Significant reduction in mortality and cardiovascular events in patients aged 80 and over when treated with hypertensive agents].
Rev Med Suisse; 2008 Jun; 4(160):1412. PubMed ID: 18630065
[No Abstract] [Full Text] [Related]
2. Antihypertensive treatment in the very elderly shows significant mortality benefit.
Cardiovasc J Afr; 2008; 19(3):169-71. PubMed ID: 18568185
[No Abstract] [Full Text] [Related]
3. Older age should not be a barrier to the treatment of hypertension.
Aronow WS
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):514-5. PubMed ID: 18607394
[TBL] [Abstract][Full Text] [Related]
4. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
5. Study shows benefit of hypertension help after 80.
Johns Hopkins Med Lett Health After 50; 2008 Sep; 20(7):7. PubMed ID: 18822530
[No Abstract] [Full Text] [Related]
6. Outcomes for new anti-hypertensives in the elderly.
Johnson KH; Chappelle CM
J Fam Pract; 2000 Feb; 49(2):111, 183. PubMed ID: 10718686
[No Abstract] [Full Text] [Related]
7. [Threshold and target blood pressures for treating hypertension. The facts].
Holzgreve H
MMW Fortschr Med; 2005 Apr; 147(15):45-6. PubMed ID: 15884503
[No Abstract] [Full Text] [Related]
8. Hypertension: a review and rationale of treatment.
Copley JB; Rosario R
Dis Mon; 2005; 51(10-11):548-614. PubMed ID: 16360376
[No Abstract] [Full Text] [Related]
9. Will ASCOT change the form of anti-hypertensive therapy?
Bilous R
Diabet Med; 2006 Jan; 23(1):13-4. PubMed ID: 16409559
[No Abstract] [Full Text] [Related]
10. What we really need to do to reduce cardiovascular events in hypertensive patients.
Ong HT
J Fam Pract; 2007 Sep; 56(9):727-34. PubMed ID: 17764644
[No Abstract] [Full Text] [Related]
11. [Evidence from large clinical trials for Japanese hypertensive patients].
Okura T; Higaki J
Nihon Rinsho; 2011 Nov; 69(11):1934-40. PubMed ID: 22111311
[TBL] [Abstract][Full Text] [Related]
12. Management of older hypertensive patients.
Hedner T; Kjeldsen S; Oparil S; Narkiewics K
Blood Press; 2008; 17(4):184-5. PubMed ID: 18932064
[No Abstract] [Full Text] [Related]
13. [Treatment of hypertension in people over 80 years should not be discontinued].
Thien T; Deinum J
Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1713-6. PubMed ID: 18727600
[TBL] [Abstract][Full Text] [Related]
14. [Antihypertensive therapy].
Schmieder RE; Veelken R
MMW Fortschr Med; 2009 Apr; 151(14):95-8; quiz 99. PubMed ID: 19504848
[No Abstract] [Full Text] [Related]
15. Antihypertensive drugs in daily clinical practice: are there differences between genders?
Barrios V; Escobar C; Echarri R; Jimenez-Nacher JJ
Eur Heart J; 2009 Mar; 30(5):624. PubMed ID: 19147607
[No Abstract] [Full Text] [Related]
16. [Hypertension, physician's honour and TV].
Nilsson PM
Lakartidningen; 2003 Nov; 100(48):4010. PubMed ID: 14717097
[No Abstract] [Full Text] [Related]
17. [The HOT study].
Klovning A; Sandvik H; Straand J
Tidsskr Nor Laegeforen; 1999 Jan; 119(3):407. PubMed ID: 10074841
[No Abstract] [Full Text] [Related]
18. Stroke in the elderly treated for systolic hypertension (SHEP) part II--mortality.
Singer RB
J Insur Med; 1992; 24(1):28-31. PubMed ID: 10148474
[No Abstract] [Full Text] [Related]
19. Mild hypertension: treat patients, not populations.
Ramsay LE
J Hypertens; 1985 Oct; 3(5):449-55. PubMed ID: 3905961
[No Abstract] [Full Text] [Related]
20. [Has the HOT study taught us something new?].
Thelle DS
Tidsskr Nor Laegeforen; 1999 Jan; 119(3):353. PubMed ID: 10074827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
